Sinopharm Group Co (SHTDF) Stock Statistics & Valuation Metrics

Sinopharm Group Co has a market cap or net worth of $6.83B. The enterprise value is $183.65B.

Market Cap

$6.83B

Enterprise Value

$183.65B

Sinopharm Group Co has 1,341,810,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,341,810,800

Owned by Insiders

―

Owned by Institutions

24.49%

Sinopharm Group Co’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 5.63%.

Return on Equity (ROE)

0.09

Return on Assets (ROA)

0.02

Return on Invested Capital (ROIC)

5.63%

Return on Capital Employed (ROCE)

0.11

Revenue Per Employee

6.06M

Profits Per Employee

75.39K

Employee Count

94,910

Asset Turnover

1.47

Inventory Turnover

8.42

The current PE Ratio of Sinopharm Group Co is 6.05. Sinopharm Group Co’s PEG ratio is 1.88.

PE Ratio

6.05

PS Ratio

0.07

PB Ratio

0.50

Price to FCF

2.27

Price to Operating Cash Flow

2.11

PEG Ratio

1.88

In the last 12 months, Sinopharm Group Co had revenue of 575.17B and earned 7.16B in profits. Earnings per share was 2.29.

Revenue

575.17B

Gross Profit

41.67B

Operating Income

16.04B

Pretax Income

14.80B

Net Income

7.16B

EBITDA

21.52B

Earnings Per Share (EPS)

2.29

In the last 12 months, operating cash flow was 20.16B and capital expenditures -1.47B, giving a free cash flow of 18.69B billion.

Operating Cash Flow

20.16B

Free Cash Flow

18.69B

Free Cash Flow per Share

5.99

Sinopharm Group Co pays an annual dividend of $0.10, resulting in a dividend yield of 4.41%

Dividend Per Share

$0.10

Dividend Yield

4.41%

Payout Ratio

30.02%

Free Cash Flow Yield

41.03%

Earnings Yield

15.47%

Beta

0.60

52-Week Price Change

-16.64%

50-Day Moving Average

2.00

200-Day Moving Average

2.23

Relative Strength Index (RSI)

53.60

Average Volume (3m)

60.64K

Sinopharm Group Co upcoming earnings date is Mar 19, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 25, 2026

Next Earnings Date

Mar 19, 2027

Ex-Dividend Date

Jun 25, 2026

Sinopharm Group Co as a current ratio of 1.41, with Debt / Equity ratio of 129.33%

Current Ratio

1.41

Quick Ratio

1.15

Debt to Market Cap

1.23

Net Debt to EBITDA

2.19

Interest Coverage Ratio

6.97

In the past 12 months, Sinopharm Group Co has paid 3.97B in taxes.

Income Tax

3.97B

Effective Tax Rate

0.27

Sinopharm Group Co EV to EBITDA ratio is 3.91, with an EV/FCF ratio of 4.55.

EV to Sales

0.15

EV to EBITDA

3.91

EV to Free Cash Flow

4.55

EV to Operating Cash Flow

4.22

Sinopharm Group Co has $41.88B in cash and marketable securities with $81.32B in debt, giving a net cash position of -$39.44B billion.

Cash & Marketable Securities

$41.88B

Total Debt

$81.32B

Net Cash

-$39.44B

Net Cash Per Share

-$29.39

Tangible Book Value Per Share

$41.12

Gross margin is 7.03%, with operating margin of 2.95%, and net profit margin of 1.24%.

Gross Margin

7.03%

Operating Margin

2.95%

Pretax Margin

2.54%

Net Profit Margin

1.24%

EBITDA Margin

3.83%

EBIT Margin

3.11%

The average price target for Sinopharm Group Co is $2.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

$2.67

Price Target Upside

25.19% Upside

Analyst Consensus

Strong Buy

Analyst Count

3

Revenue Growth Forecast

2.49%

EPS Growth Forecast

7.44%

Smart Score

5

AI Score

―